Bridging the Gap between Bio-Pharmaceuticals,
CROs, Clinical Investigators and Trial Participants

Trial Patient Randomization: yet another tool…

On average, a Clinical Site or Investigator participating in a Clinical Trial has to login to as much as 5 – 6 different systems, each requiring its own User credentials. Needless to say that this is a nightmare for a Clinical Site.

In most studies, trial patient Randomization is outsourced to a third-party, with its own system for User registration. Sites have to be defined again in the third-party software, and information from the third-party software has to transferred back into other systems in order to get an overview of randomized patients per site. It is just ‘yet another’ tool, only used to Randomize a trial patient.

Integration of Randomization into our Clinical Research Portal

In our Clinical Study-Portal, the Randomization program can be seamlessly integrated in the Clinical Investigator web-Portal. Each participating clinical Site or Investigator already has a User account, and all relevant information on Clinical Sites is already known within the Portal database. Data on Randomized trial patients can directly be used to create reports on patient flow. Again, all within the same web-based system. And using the same high standards for security and usability.

By using our role-based access model, you can decide which action is allowed for a given role. E.g. Trial coordinators can nominate investigators and can start or close patient recruitment. You can also use the available communication toolset to be notified via email on events such as randomization.